SENSEI BIOTHERAPEUTICS INC Share Price Today: Live Updates & Key Insights

SENSEI BIOTHERAPEUTICS INC share price today is $31.74, up 3.31%. The stock opened at $32 against the previous close of $30.55, with an intraday high of $33.62 and low of $31.035.

SENSEI BIOTHERAPEUTICS INC Share Price Chart

SENSEI BIOTHERAPEUTICS INC

us-stock
To Invest in {{usstockname}}
us-stock

SENSEI BIOTHERAPEUTICS INC Share Price Performance

$31.74 0.0331(3.31%) SNSE at 23 Mar 2026 03:16 PM Biotechnology
Lowest Today 31.035
Highest Today 33.62
Today’s Open 32
Prev. Close 30.55
52 Week High 36.76
52 Week Low 5.00
Day’s Range: Low 31.035 High 33.62
52-Week Range: Low 5.00 High 36.76
1 day return -
1 Week return +4.91
1 month return -3.4
3 month return +235.46
6 month return +249.61
1 year return +7380.4
3 year return +2087.5
5 year return +110.77
10 year return -

SENSEI BIOTHERAPEUTICS INC Institutional Holdings

Ikarian Capital, LLC 1.78

Catalio Capital Management, LP 1.17

Renaissance Technologies Corp 0.91

Vanguard Institutional Extnd Mkt Idx Tr 0.61

Fidelity Extended Market Index 0.38

Fidelity Total Market Index 0.11

Fidelity Series Total Market Index 0.10

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

UBS Group AG 0.07

Bank of America Corp 0.05

Spartan Total Market Index Pool G 0.05

NT Ext Equity Mkt Idx Fd - NL 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.02

DFA US Vector Equity Class F 0.01

State St US Extended Mkt Indx NL Cl C 0.01

DFA US Core Equity 2 I 0.01

Fidelity Nasdaq Composite Index 0.01

JPMorgan Chase & Co 0.01

SSgA U.S. Total Market Index Strategy 0.01

State St US Ttl Mkt Indx NL Cl A 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

BNYM Mellon NSL Mkt Completion Fund Inst 0.00

Spartan Extended Market Index Pool F 0.00

Morgan Stanley - Brokerage Accounts 0.00

BNP Paribas Arbitrage, SA 0.00

SBI Securities Co Ltd 0.00

Vanguard Group Inc 0.00

SENSEI BIOTHERAPEUTICS INC Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

SENSEI BIOTHERAPEUTICS INC Fundamentals

Market Cap 39.82 M

PB Ratio 1.7307

PE Ratio 0.0

Enterprise Value 16.80 M

Total Assets 45.36 M

Volume 108190

SENSEI BIOTHERAPEUTICS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-38919000 -38.9M, FY22:-48807000 -48.8M, FY21:-37464000 -37.5M, FY20:-20629000 -20.6M, FY19:-18995000 -19.0M

Quarterly Revenue Q3/2025:-4851000 -4.9M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-37000 -0.0M, Q1/2025:-30000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-135000 -0.1M

Quarterly Net worth Q3/2025:-4569000 -4.6M, Q2/2025:-4936000 -4.9M, Q1/2025:-6864000 -6.9M, Q3/2024:-7253000 -7.3M, Q2/2024:-7142000 -7.1M

About SENSEI BIOTHERAPEUTICS INC & investment objective

Company Information Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SENSEI BIOTHERAPEUTICS INC FAQs

What is the share price of SENSEI BIOTHERAPEUTICS INC today?

The current share price of SENSEI BIOTHERAPEUTICS INC is $31.74.

Can I buy SENSEI BIOTHERAPEUTICS INC shares in India?

Yes, Indian investors can buy SENSEI BIOTHERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy SENSEI BIOTHERAPEUTICS INC shares in India?

You can easily invest in SENSEI BIOTHERAPEUTICS INC shares from India by:

Can I buy fractional shares of SENSEI BIOTHERAPEUTICS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SENSEI BIOTHERAPEUTICS INC?

SENSEI BIOTHERAPEUTICS INC has a market cap of $39.82 M.

In which sector does SENSEI BIOTHERAPEUTICS INC belong?

SENSEI BIOTHERAPEUTICS INC operates in the Biotechnology sector.

What documents are required to invest in SENSEI BIOTHERAPEUTICS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of SENSEI BIOTHERAPEUTICS INC?

The PE ratio of SENSEI BIOTHERAPEUTICS INC is N/A and the PB ratio is 1.73.